Zobrazeno 1 - 10
of 1 173
pro vyhledávání: '"Cardiovascular drugs"'
Autor:
Sofia Svahn, Leona Appelblad, Hugo Lövheim, Yngve Gustafson, Birgitta Olofsson, Maria Gustafsson
Publikováno v:
BMC Geriatrics, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Purpose The aim of this study was to describe a population of very old people with heart failure (HF), to analyse the use of cardiovascular drugs over time, and to explore factors influencing cardiovascular drug treatment for this group. Met
Externí odkaz:
https://doaj.org/article/3251656ecc73456ea31fad29f93018e3
Publikováno v:
Cancer Medicine, Vol 13, Iss 5, Pp n/a-n/a (2024)
Abstract Background Due to encouraging pre‐clinical data and supportive observational studies, there has been growing interest in applying cardiovascular drugs (including aspirin, angiotensin‐converting enzyme [ACE] inhibitors, statins, and metfo
Externí odkaz:
https://doaj.org/article/b7d28d4620fe493daf01d03b019e29e1
Publikováno v:
Trakia Journal of Sciences, Vol 21, Iss 1, Pp 43-47 (2023)
PURPOSE. To evaluate the incidence of urticarial adverse drug reactions (ADRs) to ACE inhibitors and beta-blockers, patient demographics, drug causality, and treatment outcome. METHODS. An epidemiological study including 154 patients with urticaria
Externí odkaz:
https://doaj.org/article/b5ddbea3a98b49019aa3ab9babd2fc79
Autor:
Ashenafi Kibret Sendekie, Asrat Elias Ergena, Eyayaw Ashete Belachew, Asmamaw Emagn Kasahun, Masho Tigabie Teklie, Adeladlew Kassie Netere
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 16, Iss 1, Pp 1-10 (2023)
Abstract Background Critical actions are required for the proper administration of medications to patients with cardiovascular diseases. However, there has been an increase in irrational use of cardiovascular drugs. The purpose of this study was to d
Externí odkaz:
https://doaj.org/article/337a73a423d44a029bbc263b98314d4d
Autor:
Pajović Vladislav, Žigon Nina
Publikováno v:
Medicinski Podmladak, Vol 74, Iss 2, Pp 1-6 (2023)
Individual variations in the patient's response to the administered drugs are a frequent and important clinical problem in medicine and pharmacology. It is especially important to consider these issues when counting cardiovascular disease (CVD) treat
Externí odkaz:
https://doaj.org/article/4dbfdffea753476489c7e7e34a65cb30
Publikováno v:
Pharmaceuticals, Vol 17, Iss 2, p 199 (2024)
Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are commonly used diabetes and obesity medications but have been associated with gastrointestinal (GI) adverse events. However, real-world evidence on comparative GI adverse reaction p
Externí odkaz:
https://doaj.org/article/eab50e0709514a8ca9a78517d82426ab
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: The COVID-19 epidemic has disrupted care and access to care in many ways. It was accompanied by an excess of cardiovascular drug treatment discontinuations. We sought to investigate a deeper potential impact of the COVID-19 epidemic on an
Externí odkaz:
https://doaj.org/article/547b4f5983024e6690b37191b7830203
Publikováno v:
Heliyon, Vol 9, Iss 5, Pp e15933- (2023)
Biosynthesis of nanoparticles is increasingly becoming popular due to the demand for sustainable technologies worldwide. In the present investigation, Acmella oleracea plant extract fuelled combustion technique followed by calcination at 600 °C was
Externí odkaz:
https://doaj.org/article/b2f2a07a893343848c6fedb79fec9184
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.